# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001737287-20-000027
Filing Date
2020-05-06
Accepted
2020-05-06 16:18:27
Documents
70
Period of Report
2020-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | allo-20200331.htm iXBRL | 10-Q | 1694489
2 | EX-10.1 | allo-2020331xex101.htm | EX-10.1 | 178682
3 | EX-31.1 | allo-20200331xex311.htm | EX-31.1 | 11479
4 | EX-31.2 | allo-20200331xex312.htm | EX-31.2 | 11501
5 | EX-32.1 | allo-20200331xex321.htm | EX-32.1 | 9733
11 |  | allogenelogo1.jpg | GRAPHIC | 125971
12 |  | allogenelogo2.jpg | GRAPHIC | 125971
13 |  | allogenelogo3.jpg | GRAPHIC | 125971
14 |  | allogenelogo4.jpg | GRAPHIC | 125971
15 |  | allogenelogo5.jpg | GRAPHIC | 125971
16 |  | image11.jpg | GRAPHIC | 413
| Complete submission text file | 0001737287-20-000027.txt |  | 7726430

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | allo-20200331.xsd | EX-101.SCH | 41606
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | allo-20200331_cal.xml | EX-101.CAL | 62153
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | allo-20200331_def.xml | EX-101.DEF | 212717
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | allo-20200331_lab.xml | EX-101.LAB | 534408
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | allo-20200331_pre.xml | EX-101.PRE | 335053
28 | EXTRACTED XBRL INSTANCE DOCUMENT | allo-20200331_htm.xml | XML | 1157911

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38693 | Film No.: 20852857
SIC: 2836 Biological Products, (No Diagnostic Substances)